Lower Incidence of Hypoglycemia With Angiotensin Receptor Blocker Versus ACE Inhibitor Therapy in People With or Without Diabetes.
| Autor: | Khanimov I; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Zingerman B; Department of Nephrology at the Hasharon Campus, Rabin Medical Center, Petah Tikva, Israel., Rozen-Zvi B; Department of Nephrology at the Hasharon Campus, Rabin Medical Center, Petah Tikva, Israel., Shimonov M; Department of Surgery A, Edith Wolfson Medical Center, Holon, Israel., Leibovitz E; Department of Internal Medicine A, Yoseftal Medical Center, Eilat, Israel.; Research Unit of the Surgical Division, Edith Wolfson Medical Center, Holon, Israel.; The Adelson School of Medicine, Ariel University, Ariel, Israel. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Clinical diabetes : a publication of the American Diabetes Association [Clin Diabetes] 2024 Spring; Vol. 42 (2), pp. 300-307. Date of Electronic Publication: 2024 Jan 12. |
| DOI: | 10.2337/cd23-0039 |
| Abstrakt: | This article describes a study examining the association between treatment with ACE inhibitors or angiotensin receptor blockers (ARBs) and incident hypoglycemia in patients with or without diabetes who were admitted to the internal medicine departments of a tertiary hospital in the Tel Aviv district of Israel. The authors found that treatment with ARBs, but not ACE inhibitors, compared with treatment with neither, was associated with a reduced risk of hypoglycemia regardless of diabetes status. Competing Interests: No potential conflicts of interest relevant to this article were reported. (©2024 by the American Diabetes Association.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|